Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel cannabinoid CB1/CB2 receptor modulators emerge from Solvay R&D

July 22, 2005

Structure disclosed for TPI-287

July 22, 2005

Novel agents imparted for asthma and other inflammatory and allergic disorders

July 21, 2005

Novel agents for premature ejaculation in development at Pfizer

July 21, 2005

Novel analgesic agents claimed in recent patent literature

July 21, 2005

LG Life Sciences claims new agents for acute hepatitis, liver cirrhosis and rheumatoid arthritis

July 20, 2005

Recent patents describe novel antibacterial agents

July 20, 2005

Novel antithrombotic agents reported in recent patent literature

July 19, 2005

Recent patents cover therapeutic agents for cognitive impairment and neurodegeneration

July 19, 2005

Cysteine protease cathepsin inhibitors from Celera Genomics

July 18, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...